The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity by KD Kaplanov, TYu Klitochenko3, AL Shipaeva, MN Shirokova, IV Matveeva, NB Lavrishina

Get full text

Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry by KD Kaplanov, NP Volkov, TYu Klitochenko, IV Matveeva, AL Shipaeva, MN Shirokova, NV Davydova, EG Gemdzhian

Get full text

First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness by KD Kaplanov, NP Volkov, TYu Klitochenko, AL Shipaeva, IV Matveeva, MN Shirokova, AC Proskurina, NA Red’kina, EG Gemdzhyan

Get full text

Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues by KD Kaplanov, NP Volkov, TYu Klitochenko, IV Matveeva, AL Shipaeva, MN Shirokova, NV Davydov, EG Gemdzhian, DS Abramov, DM Konovalov, GL Snigur, NA Red’kina

Get full text

Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice by AG Turkina, NV Novitskaya, AK Golenkov, VA Shuvaev, LI Napso, V Krylova, AM Savrilova, GSh Safuanova, AV Korobkin, TYu Klitochenko, EV Burnasheva, EV Vasil’ev, OM Senderova, EYu Fedorova, LM Yalunina, EK Nekhai, GB Kuchma, AS Lyamkina, NG Shchedrova

Get full text